Original news and analysis on international IP policy
On the last day of the weeklong meeting of the WIPO committee on the law of patents, discussions are ongoing to find consensus on the future work of the committee. The week has been a theatre of strong stances dividing developed and developing countries on areas such as patents on health, patent flexibilities and the quality of patents.
A set of documents in use by today's closed-door negotiations on research and development for neglected diseases at the World Health Assembly lay out the core differences between WHO members. Negotiations are expected to last into the night as members try to agree on how to take forward recommendations from a key report - including to negotiate a binding convention on R&D for diseases left behind in the marketplace.
The chair of the World Intellectual Property Organization patent committee today circulated informal suggestions on ways forward for this week's wide-ranging committee agenda.
Members of the World Health Organization tonight will consider a draft decision on how the organisation will address the prevention and control of noncommunicable diseases, such as tobacco use, unhealthy diet, physical inactivity and harmful use of alcohol.
A drafting group has embarked on the task of combining four different proposals on the table at the annual World Health Assembly aimed at financing research and development for neglected diseases mostly afflicting poorer populations.
Members of the World Health Organization at their annual meeting tomorrow will address proposals for ways to finance research and development for diseases which afflict mainly developing countries but for which there are not lucrative markets.
The annual World Health Assembly being held this week has a rare chance to achieve a breakthrough on health research for the global poor if it can agree to move forward on a proposed convention, proponents said at a recent meeting.
The law of patents is being discussed this week at the World Intellectual Property Organization with a focus on the potentially difficult issues of limitations and exceptions, high quality patents, and patents related to public health.
World Health Organization Director General Margaret Chan today opened the annual assembly of the UN agency’s member states with a positive outlook on the future of public health. At a time of economic uncertainty, she called on countries to be efficient in their spending, to take ownership of the health of their people, and to look toward innovative health solutions.
The escalating battle between Big Pharma and India’s generic drug manufacturers is pushing down medicine prices in one of the world’s fastest growing pharmaceutical markets.
On the eve of the World Health Assembly, the permanent mission of Brazil organised an informal meeting on sanitary regulation and how to improve cooperation among drug regulatory agencies. Major stakeholders were invited to present challenges and ongoing efforts to improve global quality, safety and efficacy of medical products.
BOSTON - Early stage innovation is still strong in the United States, but parties need to work better together and address bottlenecks in the middle stages, a panel of university and private sector experts said this week. Meanwhile, the president of global biotechnology company Genzyme said the industry is not in crisis and the company is hopeful about its recent merger with Sanofi.